We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPRO icon
301
Expro Ltd
XPRO
$1.71B
$2.65M 0.08%
17,858
SU icon
302
Suncor Energy
SU
$78.8B
$2.65M 0.08%
75,861
+41,400
+120% +$1.38M
OKS
303
DELISTED
Oneok Partners LP
OKS
$2.65M 0.08%
49,500
-200
-0.4% -$10.6K
MGM icon
304
MGM Resorts International
MGM
$11.7B
$2.65M 0.08%
102,433
-28,495
-22% -$734K
MAA icon
305
Mid-America Apartment Communities
MAA
$15.5B
$2.63M 0.08%
38,490
+26,430
+219% +$1.73M
DOV icon
306
Dover
DOV
$27.5B
$2.62M 0.08%
39,627
-9,401
-19% -$585K
GPOR
307
DELISTED
Gulfport Energy Corp.
GPOR
$2.62M 0.08%
36,770
-9,569
-21% -$588K
JCI icon
308
Johnson Controls International
JCI
$87.8B
$2.62M 0.08%
52,796
+34,620
+190% +$1.75M
GDX icon
309
VanEck Gold Miners ETF
GDX
$23.5B
$2.61M 0.08%
110,647
+36,286
+49% +$891K
FTI icon
310
TechnipFMC
FTI
$27.5B
$2.61M 0.08%
67,037
-8,375
-11% -$317K
SMCI icon
311
Super Micro Computer
SMCI
$17.9B
$2.6M 0.08%
1,498,200
IOC
312
DELISTED
Interoil Corporation
IOC
$2.6M 0.08%
40,070
+10,454
+35% +$576K
RY icon
313
Royal Bank of Canada
RY
$292B
$2.59M 0.08%
39,194
-402
-1% -$26K
MOS icon
314
The Mosaic Company
MOS
$7.24B
$2.58M 0.08%
51,637
+428
+0.8% +$20.4K
VEA icon
315
Vanguard FTSE Developed Markets ETF
VEA
$230B
$2.58M 0.08%
62,479
+33,694
+117% +$1.38M
CMS icon
316
CMS Energy
CMS
$22.7B
$2.55M 0.08%
87,254
-404
-0.5% -$11.2K
NOC icon
317
Northrop Grumman
NOC
$76B
$2.55M 0.08%
20,702
+416
+2% +$49.3K
MPV
318
Barings Participation Investors
MPV
$174M
$2.55M 0.08%
191,869
+1,324
+0.7% +$17.9K
DOC icon
319
Healthpeak Properties
DOC
$15.2B
$2.54M 0.08%
71,887
+51,101
+246% +$1.76M
RCI icon
320
Rogers Communications
RCI
$18.4B
$2.54M 0.08%
61,180
-565
-0.9% -$23K
UPGD icon
321
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$119M
$2.52M 0.08%
73,451
+581
+0.8% +$19.5K
RHP icon
322
Ryman Hospitality Properties
RHP
$8.41B
$2.52M 0.08%
59,259
+520
+0.9% +$22K
EXPD icon
323
Expeditors International
EXPD
$21.8B
$2.51M 0.08%
63,393
-3,741
-6% -$153K
LUMN icon
324
Lumen
LUMN
$6.76B
$2.5M 0.08%
76,266
-6,459
-8% -$198K
CME icon
325
CME Group
CME
$96.1B
$2.5M 0.08%
33,787
+197
+0.6% +$14.9K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.